Concepedia

Publication | Open Access

Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins

DOIFull Paper Access

267

Citations

19

References

2015

Year

Luís Querol, Ricard Rojas‐García, Jordi Díaz‐Manera, Joseba Bárcena, Julio Pardo, A Ortega-Moreno, María J. Sedano, Laia Seró-Ballesteros, Alejandra Carvajal, Nicolau Ortiz,
Neurology Neuroimmunology & Neuroinflammation

Abstract

This study provides Class IV evidence that rituximab is effective for patients with treatment-resistant CIDP with IgG4 anti-CNTN1 or anti-NF155 antibodies.

References

YearCitations

Page 1